Hal Barron

Hal Barron

Director/Board Member at GSK PLC

Net worth: 15 M $ as of Today

64 year
Health Technology
Consumer Services
Commercial Services

Profile

Hal V. Barron occupies the position of Executive Director & Chief Scientific Officer at GlaxoSmithKline Plc. Dr. Barron is also on the board of GRAIL, Inc. and Cardiologist at UCSF Medical Center and Adjunct Professor at The University of California, San Francisco. Dr. Barron previously occupied the position of Director & Senior Vice President-Development at Arête Therapeutics, Inc., Chief Medical Officer & Executive Vice President at Roche & Genentech, Inc., President for Tesaro, Inc., Chief Medical Officer & EVP-Global Development at Genentech, Inc., Chief Medical Officer & Executive Vice President at F. Hoffmann-La Roche Ltd., Chief Medical Officer & Executive Vice President at Roche Pharmaceuticals, Inc. and President-Research & Development at Calico LLC. He received a doctorate from Yale University and an undergraduate degree from Washington University in St. Louis.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
GSK PLC
0.01%
2026-05-14 602,274 ( 0.01% ) 15 M $ 2026-05-30
-.--%
2026-06-04 255,833 ( -.--% ) - $ Today

Hal Barron active positions

CompaniesPositionStart
GSK PLC Director/Board Member 2017-12-31
Chief Executive Officer 2022-07-31
Corporate Officer/Principal -
Corporate Officer/Principal -

Former positions of Hal Barron

CompaniesPositionEnd
JUNO THERAPEUTICS INC Director/Board Member 2018-03-05
Chief Tech/Sci/R&D Officer 2017-11-30
Chief Tech/Sci/R&D Officer 2013-10-31
Chief Tech/Sci/R&D Officer 2013-10-31
ALEXZA PHARMACEUTICALS, INC. Director/Board Member 2013-05-20
See the detail of Hal Barron's experience

Training of Hal Barron

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

91

1st degree connections

16

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies16

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!